ACR Convergence 2020

Complete Coverage

ACR 2020 Debate: JAK Inhibitors vs Biologics After Methotrexate Failure in RA

By

Meghna Rao

Belimumab Plus Standard Therapy Improves Renal Outcomes in Patients With Active Lupus Nephritis

By

Emily Pond

Study Supports Safety, Efficacy of Tofacitinib in the Treatment of Ankylosing Spondylitis

By

Emily Pond

Cross-Cutting Disease Factors Predictive of Mental Health in Youth With Rheumatologic Disease

By

Amit Akirov, MD

Assessing the Effect of Cannabis Use on Pain in Rheumatic Diseases

By

Marissa Purdy

Comparative Performances of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Gout in Type 2 Diabetes

By

Rheumatology Advisor Contributing Writer

Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis

By

Rheumatology Advisor Contributing Writer

Low LDL Associated With Coronary Atherosclerosis Burden, CVD Risk in Non-Obese Patients With RA

By

Florence Chaverneff, PhD

Avacopan Superior to Standard Therapy in Renal Function in ANCA-Associated Vasculitis

By

Amit Akirov, MD

Healthcare Providers Recognize Potential Benefits of Telemedicine in Pediatric Rheumatology During the COVID-19 Pandemic

By

Sabrina Mammen